Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Filings indexed 2,308 across all filing types
Latest filing 2012-04-13 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 100% confidence The document text explicitly discusses Novozymes initiating a share buyback program ('aktietilbagekøbsprogram') under a specific EU regulation (Commission Regulation No 2273/2003). This action directly relates to the company transacting in its own shares. The classification code 'POS' (Transaction in Own Shares) is the most appropriate fit for reporting share repurchases or issuances. The document is short and appears to be an announcement, but the core subject matter is the transaction itself, making POS more specific than RPA or RNS.
2012-04-13 Danish
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 99% confidence The document details specific transactions related to Novozymes' share buyback program ('aktietilbagekøbsprogram') conducted under the 'Safe Harbour' regulation. It reports the number of shares bought back, the average purchase price, and the total value of these transactions over a specific period (April 4 to April 12, 2012). This content directly relates to the company acquiring its own shares, which corresponds precisely to the definition of 'Transaction in Own Shares'. The document is a formal announcement detailing these share repurchases.
2012-04-13 English
Director's Dealing 2012
Director's Dealing
2012-04-04 Danish
Director's Dealing 2012
Director's Dealing
2012-04-04 English
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 100% confidence The document text explicitly discusses Novozymes initiating a share buyback program ('aktietilbagekøbsprogram') under a specific EU regulation ('Safe Harbour'-regulativet) for a defined period and total amount (up to 1,000 million DKK). This directly relates to the company purchasing its own shares. Based on the definitions, this corresponds to 'Transaction in Own Shares' (POS). The document is very short and appears to be an announcement of this activity.
2012-03-30 Danish
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made under a share buyback program initiated by Novozymes, referencing the European Commission's Safe Harbour Regulation. It provides tables showing the number of shares bought back, the average purchase price, and the total transaction value over specific dates (March 23 to March 29, 2012). This content directly corresponds to the definition of a report concerning the company buying back or selling its own shares. Therefore, the appropriate classification is Transaction in Own Shares (POS). The document length is short (2925 chars), but it is a detailed report of transactions, not merely an announcement that a report is available (RPA/RNS).
2012-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.